Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.
作者信息
Retsas S, Leslie M, Bottomley D
机构信息
Medical Oncology Unit, Westminster Hospital, London.
出版信息
BMJ. 1989 May 13;298(6683):1290-1. doi: 10.1136/bmj.298.6683.1290.
Abstract
摘要
相似文献
1
Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.病灶内注射肿瘤坏死因子联合γ干扰素治疗转移性黑色素瘤
BMJ. 1989 May 13;298(6683):1290-1. doi: 10.1136/bmj.298.6683.1290.
2
A pilot study of recombinant human TNF and interferon-gamma in four patients with refractory AML.重组人肿瘤坏死因子和干扰素-γ用于4例难治性急性髓系白血病患者的初步研究。
Eur J Haematol. 1992 Feb;48(2):115-6. doi: 10.1111/j.1600-0609.1992.tb00576.x.
3
Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan.日本黑色素瘤采用干扰素、细胞因子及其他生物反应调节剂治疗的现状
J Invest Dermatol. 1989 May;92(5 Suppl):326S-328s. doi: 10.1111/1523-1747.ep13076752.
4
High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer.
Eur J Cancer. 1995 Jun;31A(6):1009-16. doi: 10.1016/0959-8049(94)00512-5.
5
Regional therapy of melanoma.黑色素瘤的区域治疗
Eur J Cancer. 1993;29A(4):606-12. doi: 10.1016/s0959-8049(05)80163-7.
6
Isolation perfusion with tumor necrosis factor-alpha, interferon-gamma, and hyperthermia in the treatment of localized and metastatic cancer.
Recent Results Cancer Res. 1995;138:161-6. doi: 10.1007/978-3-642-78768-3_18.
7
[Value of isolation-perfusion of the limbs in melanomas and sarcomas].[肢体隔离灌注在黑色素瘤和肉瘤中的价值]
Ann Chir. 1995;49(1):9-12.
8
Influence of intravesical administration of tumor necrosis factor alpha and systemic gamma-interferon on murine bladder cancer: lack of dose response.膀胱内注射肿瘤坏死因子α和全身应用γ干扰素对小鼠膀胱癌的影响：缺乏剂量反应。
Urol Res. 1990;18(4):287-9. doi: 10.1007/BF00294775.
9
The synergism of gamma-interferon and tumor necrosis factor in whole body hyperthermia with vitamin C to control toxicity.γ-干扰素与肿瘤坏死因子在全身热疗联合维生素C控制毒性方面的协同作用。
Med Hypotheses. 1992 Jul;38(3):257-8. doi: 10.1016/0306-9877(92)90106-m.
10
Tetramodality treatment of human melanoma in vitro.人黑色素瘤的体外四模态治疗
Melanoma Res. 1995 Feb;5(1):49-57. doi: 10.1097/00008390-199502000-00006.
引用本文的文献
1
Intratumoral therapies and in-situ vaccination for melanoma.肿瘤内治疗和原位疫苗接种治疗黑色素瘤。
Hum Vaccin Immunother. 2022 May 31;18(3):1890512. doi: 10.1080/21645515.2021.1890512.
2
Establishment of a human fibroblast cell line producing tumor necrosis factor alpha (KMST-6/TNF) and growth inhibitory effects of its conditioned medium on malignant cells in culture.产生肿瘤坏死因子α的人成纤维细胞系（KMST-6/TNF）的建立及其条件培养基对培养的恶性细胞的生长抑制作用。
In Vitro Cell Dev Biol Anim. 1998 Jun;34(6):463-7. doi: 10.1007/s11626-998-0079-9.
3
Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.肿瘤坏死因子-α在体外抑制干细胞因子诱导的人骨髓祖细胞增殖。p55和p75肿瘤坏死因子受体的作用。
J Clin Invest. 1994 Jul;94(1):165-72. doi: 10.1172/JCI117303.
4
Synergistic cytotoxicity of human recombinant tumour necrosis factor alpha combined with microtubule effectors.人重组肿瘤坏死因子α与微管效应物联合的协同细胞毒性
J Cancer Res Clin Oncol. 1991;117(3):239-43. doi: 10.1007/BF01625431.
5
A YIGSR-containing novel mutein without the detrimental effect of human TNF-alpha of enhancing experimental pulmonary metastasis.一种含YIGSR的新型突变蛋白，无人类肿瘤坏死因子-α增强实验性肺转移的有害作用。
Clin Exp Metastasis. 1992 Jul;10(4):267-72. doi: 10.1007/BF00133562.
6
In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion.
World J Surg. 1992 Mar-Apr;16(2):234-40. doi: 10.1007/BF02071526.
7
Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical data.肿瘤坏死因子α在体内改变对α干扰素的抗性：首批临床数据。
Cancer Immunol Immunother. 1992;35(5):342-6. doi: 10.1007/BF01741148.
本文引用的文献
1
A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.
J Clin Oncol. 1988 Aug;6(8):1328-34. doi: 10.1200/JCO.1988.6.8.1328.
2
Tumour necrosis factor.肿瘤坏死因子
Br Med J (Clin Res Ed). 1988 Apr 30;296(6631):1214. doi: 10.1136/bmj.296.6631.1214.
Zotero 插件